C07C 233/40
Having the carbon atom of the carboxamide group bound to an acyclic
Official title: having the carbon atom of the carboxamide group bound to an acyclic carbon atom of a carbon skeleton containing six-membered aromatic rings
C07C233/40 (Having the carbon atom of the carboxamide group bound to an acyclic) appears on 138 US grants and 94 published applications in this corpus.
Search patents in C07C- Granted patents
- 138
- Published applications
- 94
- Assignees
- 91
- Inventors
- 420
- Latest grant
- 9 Dec 2025
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1983 | 1 | 0 |
| 1984 | 1 | 0 |
| 1985 | 0 | 0 |
| 1986 | 0 | 0 |
| 1987 | 0 | 0 |
| 1988 | 0 | 0 |
| 1989 | 0 | 0 |
| 1990 | 1 | 0 |
| 1991 | 4 | 0 |
| 1992 | 4 | 0 |
| 1993 | 5 | 0 |
| 1994 | 5 | 0 |
| 1995 | 3 | 0 |
| 1996 | 11 | 0 |
| 1997 | 22 | 0 |
| 1998 | 5 | 0 |
| 1999 | 4 | 0 |
| 2000 | 4 | 0 |
| 2001 | 5 | 2 |
| 2002 | 2 | 3 |
| 2003 | 4 | 5 |
| 2004 | 0 | 4 |
| 2005 | 1 | 7 |
| 2006 | 3 | 2 |
| 2007 | 4 | 4 |
| 2008 | 1 | 10 |
| 2009 | 2 | 4 |
| 2010 | 3 | 3 |
| 2011 | 1 | 2 |
| 2012 | 4 | 4 |
| 2013 | 2 | 6 |
| 2014 | 3 | 3 |
| 2015 | 2 | 2 |
| 2016 | 3 | 2 |
| 2017 | 3 | 2 |
| 2018 | 2 | 5 |
| 2019 | 5 | 3 |
| 2020 | 4 | 3 |
| 2021 | 3 | 4 |
| 2022 | 4 | 7 |
| 2023 | 4 | 1 |
| 2024 | 1 | 3 |
| 2025 | 2 | 1 |
| 2026 | 0 | 2 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Recent patents
- 9H-fluorene derivatives or their pharmaceutically acceptable salts9 Dec 2025US 12,492,163 B2Uniwersytet Jagiellonski
- Modulators of sestrin-GATOR2 interaction and uses thereof5 Aug 2025US 12,378,263 B2Navitor Pharmaceuticals, Inc.
- Opioid receptor modulators17 Dec 2024US 12,168,648 B2Epiodyne, Inc.
- Vegetable oil-based material as a substitute for carnauba wax28 Nov 2023US 11,827,583 B2Iowa State University Research Foundation, Inc.
- Pharmaceutically acceptable salt of alkylcarbamoyl naphthalenyloxy octenoylhydroxy amide or of derivative thereof and method for preparing same23 May 2023US 11,655,207 B2CrystalGenomics, Inc.
- Spermine derivative and therapeutic use thereof for diseases30 Jul 2026US 2026/0217646 A1Institute of Basic Medical Sciences, Chinese Academy of Medical Sciences
- Modulators of sestrin-gator2 interaction and uses thereof26 Feb 2026US 2026/0055122 A1Navitor Pharmaceuticals, Inc.
- Inhibitors of antimocrobial resistance and methos using same23 Oct 2025US 2025/0325542 A1Baylor College of Medicine
- Novel compound for degradation of target protein or polypeptide by polyubiquitination26 Dec 2024US 2024/0425517 A1Prazer Therapeutics Inc.
- Branched tail lipid compounds and compositions for intracellular delivery of therapeutic agents11 Jul 2024US 2024/0226026 A1ModernaTX, Inc.
Most cited
By later US patents
- Retroviral protease inhibiting compounds159US 5,142,056 AAbbott Laboratories · 1992
- Retroviral protease inhibiting compounds109US 5,354,866 AAbbott Laboratories · 1994
- Retroviral protease inhibiting compounds94US 5,541,206 AAbbott Laboratories · 1996
- Non-steroidal ligands for the estrogen receptor64US 5,681,835 AGlaxo Wellcome Inc. · 1997
- N,N′-substituted-1,3-diamino-2-hydroxypropane derivatives56US 7,176,242 B2Elan Pharmaceuticals, Inc. · 2007